Showing results (2401-2410 of 10,003) with videos related to

Sort By:
Pageof 1,001
Leukemia & Lymphoma|April 16, 2024
Prevalence of geriatric impairments and frailty categorization among real-world patients with multiple myeloma: a prospective cohort study (MFRAIL)Imran Haider, Darryl P Leong, Martha Louzada, et al.
Leukemia & Lymphoma|April 17, 2024
Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot studyIbrahim Aldoss, Jianying Zhang, Marjorie Robbins, et al.
Leukemia & Lymphoma|April 22, 2024
Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with FLT3-mutant acute myeloid leukemiaJan Philipp Bewersdorf, Kishan K Patel, Rory M Shallis, et al.
Leukemia & Lymphoma|April 11, 2024
The mechanism of action, pharmacological characteristics, and clinical utility of the amyloid depleter birtamimab for the potential treatment of AL amyloidosisGiovanni Palladini, Michaela Liedtke, Wagner Zago, et al.
Leukemia & Lymphoma|May 15, 2024
Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemiaJennifer Marvin-Peek, Wei-Ying Jen, Hagop M Kantarjian, et al.
Leukemia & Lymphoma|May 6, 2024
Risk factors for treatment-related bone loss and osteoporosis in patients with follicular lymphomaYong Xing, Kaifeng Ye, Chunyuan Li, et al.
Leukemia & Lymphoma|May 2, 2024
Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal studyScott F Huntington, Wendy Y Cheng, Eric M Sarpong, et al.
Leukemia & Lymphoma|April 3, 2024
Hospital healthcare resource utilization and costs for chimeric antigen T-cell therapy and autologous hematopoietic cell transplant in patients with large B-cell lymphoma in the United StatesChendi Cui, Chaoling Feng, Ning Rosenthal, et al.
Leukemia & Lymphoma|April 10, 2024
Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL‑112)Juan-Manuel Sancho, Pau Abrisqueta, Abhijeet Kumar, et al.
Leukemia & Lymphoma|October 24, 2023
SETD2 mutations do not contribute to clonal fitness in response to chemotherapy in childhood B cell acute lymphoblastic leukemiaGloria P Contreras Yametti, Gabriel Robbins, Ashfiyah Chowdhury, et al.
Pageof 1,001